Stock GHDN BRAINSTORM CELL THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Brainstorm Cell Therapeutics Inc. Deutsche Boerse AG

Equities

GHDN

US10501E2019

Delayed Deutsche Boerse AG
Other stock markets
 02:12:33 2024-06-26 EDT 		5-day change 1st Jan Change
0.356 EUR +3.34% Intraday chart for Brainstorm Cell Therapeutics Inc. -1.79% +54.78%
06-20 Brainstorm Cell Therapeutics Announces Appointment of Haro Hartounian as EVP and COO CI
05-20 BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit from Longer-Term Treatment with NurOwn CI

Chart calendar Brainstorm Cell Therapeutics Inc.

bf4f.AxqeBjZXn04bfm2fEik9rUzXU4CTXsJORaZRTCpfITo.T1vSbgYUqjR_Th39SEhJmg_vFrXVP5YaDc4kOUUValxUX_1jWBL9J3E4Gg~3d1b56e30c2245cbfbaccac7e5f2a9d4

Upcoming events on Brainstorm Cell Therapeutics Inc.

2024-08-11 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)
2025-05-18 Q1 2025 Earnings Release (Projected)

Past events on Brainstorm Cell Therapeutics Inc.

2024-05-14 16:30 Q1 2024 Earnings Release
2024-04-09 08:00 Business Update Call
2024-04-01 08:05 Q4 2023 Earnings Release
2024-03-05 European Life Sciences CEO Forum
2024-03-04 18:00 MDA Clinical and Scientific Conference
2024-02-28 11:20 European Life Sciences CEO Forum
2024-02-28 07:40 European Life Sciences CEO Forum
2023-12-17 Annual General Meeting
2023-11-14 08:30 Q3 2023 Earnings Call
2023-11-14 07:05 Q3 2023 Earnings Release
2023-10-18 08:30 Business Update Call
2023-09-26 ADCOM Conference
2023-08-14 08:00 Q2 2023 Earnings Call
2023-08-14 07:05 Q2 2023 Earnings Release
2023-07-05 12:00 Gordon Research Conference
2023-06-21 09:00 Maxim Group Virtual Healthcare Conference
2023-05-15 08:00 Q1 2023 Earnings Call
2023-05-15 07:05 Q1 2023 Earnings Release
2023-03-30 08:00 Q4 2022 Earnings Call
2023-03-30 07:05 Q4 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
-14,0

EBIT
Million USD		Released
Forecast
Spread 		-23,0
-20,4
-13%		-31,7
-26,3
-20.41%		-24,5
-29,0
15.32%		-24,8
-25,9
4.18%		-21,4
-25,3
15.2%
-14,5

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-23,3
-20,5
-13.33%		-31,8
-26,1
-21.82%		-24,5
-28,7
14.93%		-24,3
-25,5
4.66%		-17,2
-25,2
31.71%
-21,9

Net income
Million USD		Released
Forecast
Spread 		-23,3
-20,2
-15.39%		-31,8
-26,1
-21.82%		-24,5
-28,7
14.93%		-24,3
-25,5
4.66%		-17,2
-23,0
25.37%
-21,9

EPS
USD		Released
Forecast
Spread 		-1,06
-0,91
-17.13%		-1,07
-0,89
-20.22%		-0,68
-0,79
13.92%		-0,66
-0,68
2.22%		-0,40
-0,56
28.57%
-0,28

Announcement Date18/02/2004/02/2128/03/2230/03/2301/04/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-5,48
-4,70
-16.49%		-7,59
-5,46
-39.14%		-6,84
-6,75
-1.39%		-4,92
-6,00
18.08%		-5,15
-6,01
14.24%		-5,45
-5,70
4.43%		-6,04
-6,00
-0.56%		-4,80
-6,33
24.1%		-2,47
-4,50
45.02%
-5,20


-5,80


-6,40

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-5,36
-4,70
-14.04%		-7,04
-5,46
-29.06%		-6,86
-6,75
-1.65%		-5,02
-6,00
16.37%		-5,06
-5,96
15.06%		-5,33
-5,65
5.71%		-1,23
-6,00
79.57%		-5,58
-6,33
11.87%		-3,40
-4,50
24.42%
-5,20


-5,80


-6,40

Net income
Million USD		Released
Forecast
Spread 		-5,36
-4,70
-14.04%		-7,04
-5,46
-29.06%		-6,86
-6,75
-1.65%		-5,02
-6,00
16.37%		-5,06
-5,96
15.06%		-5,33
-5,65
5.71%		-1,23
-6,00
79.57%		-5,58
-6,33
11.87%		-3,40
-4,50
24.42%
-5,20


-5,80


-6,40

EPS
USD		Released
Forecast
Spread 		-0,15
-0,13
-15.38%		-0,19
-0,15
-31.03%		-0,19
-0,18
-5.56%		-0,13
-0,15
10.34%		-0,14
-0,17
15.15%		-0,13
-0,15
10.34%		-0,03
-0,15
79.31%		-0,11
-0,13
15.38%		-0,05
-0,07
28.57%
-0,07


-0,06


-0,07

Announcement Date16/05/2215/08/2214/11/2230/03/2315/05/2314/08/2314/11/2301/04/2414/05/24---

Upcoming sector events for Brainstorm Cell Therapeutics Inc.

2024-07-15 01:45 ADDLIFE AB: Q2 2024 Earnings Release
2024-07-21 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-23 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-23 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
2024-07-23 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
2024-07-23 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
2024-07-24 LONZA GROUP AG: Q2 2024 Earnings Release
2024-07-25 01:00 BACHEM HOLDING AG: Q2 2024 Earnings Release
2024-07-25 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
2024-07-26 01:00 BB BIOTECH AG: Q2 2024 Earnings Release
More events

Past sector events for Brainstorm Cell Therapeutics Inc.

2024-06-07 02:57 POLARIS GROUP: May 2024 Sales and Revenue Release
2024-05-29 16:01 IMMUNOVANT, INC.: Q4 2024 Earnings Release
2024-05-23 07:00 CUREVAC N.V.: Q1 2024 Earnings Release
2024-05-22 01:00 EVOTEC SE: Q1 2024 Earnings Release
2024-05-21 17:14 ALVOTECH: Q1 2024 Earnings Release
2024-05-21 07:00 EXSCIENTIA PLC: Q1 2024 Earnings Release
2024-05-17 02:00 BIOARCTIC AB: Q1 2024 Earnings Release
2024-05-15 16:05 CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 GNI GROUP LTD.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BCLI Stock
  4. GHDN Stock
  5. Calendar Brainstorm Cell Therapeutics Inc.